Skin Cancer Screening: Making It a Priority in Your Practice

skin cancer scar stitches
skin cancer scar stitches
There are more new cases of skin cancer each year than of breast, prostate, lung, and colon cancers combined, which means skin cancer detection should become a part of almost every medical visit.

Examining a patient’s skin and identifying potential skin cancers are the responsibility of every clinician in every medical specialty. Certainly specialists in primary care and dermatology take the lead in skin cancer detection, but practitioners in many other medical specialties also have the opportunity to examine the skin. All clinicians — from the orthopedic provider, who may examine the arm and shoulder for a rotator cuff tear, to the ear, nose, and throat provider, who may tug on the patient’s ear and feel roughness at the top of the pinna (Figure 1) — have the opportunity to identify a potential skin cancer or precancerous lesion.

There are more new cases of skin cancer each year than of breast, prostate, lung, and colon cancers combined.1 This means that as clinicians, we need to be more aware of how skin cancer detection can become a part of almost every medical visit.

Figure 1. Basal cell carcinoma on the ear.

Early detection is one of the most important prognostic factors in the long-term survival of a patient with skin cancer. The early discovery of a skin cancer can be the difference between life and death, or between office-based surgery and surgery, radiation, and chemotherapy. As long as you have the opportunity to view a patient’s skin, you have the opportunity to identify a skin cancer and potentially save that patient’s life.

Risk factors for skin cancer

  • Skin that burns easily 
  • Blond or red hair 
  • History of excessive sun exposure, including tanning bed use and sunburns 
  • Diseases or treatments that suppress the immune system 
  • Personal history of skin cancer or family history of melanoma in a first-degree relative 
  • Presence of more than 50 moles, atypical moles, or large moles


The deadliest and most dangerous form of skin cancer is melanoma. Melanoma rates in the United States doubled from 1982 to 2011.2 One person dies of melanoma every 57 minutes.3

Evaluating a lesion and deciding whether a biopsy is required can be among the most daunting tasks for providers not familiar with the identification of skin cancer. Either of 2 systems can be used for this evaluation:

1. ABCDE mnemonic. This is widely endorsed in the medical community and presented to patients. A stands for asymmetry; if you draw a line down the center of a lesion, is each side a mirror image of the other? B stands for border; does the lesion have a clear, circular border, or is it oddly shaped, like a paisley motif? C stands for color; is the lesion of the same color throughout? D stands for diameter; is the diameter of the lesion greater than 6 mm? E stands for evolution; a new lesion or one that is changing should raise the clinician’s index of suspicion. Evolution may actually be the most important predictor within this tool. Ask your patient how long the lesion has been present and if it is changing in any way. In a retrospective study, the sensitivity of the ABCDE system for identifying a lesion as a melanoma was 97% when 1 of the 5 criteria was used and 43% when all 5 were used jointly.4 By contrast, the specificity was 36% when a single criterion was used and 100% when all 5 criteria were used.4 Sensitivity is the percentage of suspicious lesions that are correctly identified as melanomas (true diagnosis). Specificity is the percentage of suspicious lesions that are correctly identified as not being melanomas.

2. Glasgow 7-point checklist. This is another set of criteria for referral or biopsy. The presence of any major feature (see sidebar below) is an indication for biopsy. Additionally, the presence of any of the minor criteria reinforces the need for biopsy.

Glasgow 7-point checklist

Major criteria:

  • New lesion, change in size of prior lesion 
  • Change in shape 
  • Change in color

Minor criteria:

  • Diameter ≥ 7 mm 
  • Inflammation 
  • Crusting or bleeding 
  • Sensory change

As stated above, the emphasis on change as a crucial diagnostic factor should be noted. One small study found a sensitivity of 100% and a specificity of 37% when the Glasgow checklist was used in the diagnosis of 65 melanomas and 100 benign pigmented lesions.5 However, this system is less widely used and therefore less well studied than the ABCDE system at present.

This article originally appeared on Clinical Advisor